Fact Meets Function

Hydrogels based on low-methoxyl amidated citrus pectin and flaxseed gum formulated with tripeptide glycyl-l-histidyl-l-lysine improve the healing of experimental cutting wounds in rats.

Researchers evaluated hydrogels made from low-methoxyl amidated citrus pectin and flaxseed gum combined with the tripeptide GHK (glycyl-L-histidyl-L-lysine) for wound healing in a rat cutting wound model. The hydrogel formulation demonstrated improved healing outcomes in the experimental wounds compared to control groups. This is **animal model evidence** with no direct human clinical applicability at this stage.

Hydrogels based on low-methoxyl amidated citrus pectin and flaxseed gum formulated with tripeptide glycyl-l-histidyl-l-lysine improve the healing of experimental cutting wounds in rats. Read Post »

An evaluation of hydromethylthionine as a treatment option for Alzheimer’s disease.

This human clinical study evaluated hydromethylthionine (a formulation of methylene blue) as a potential therapeutic agent for Alzheimer’s disease, examining its pharmacological properties and clinical efficacy based on available evidence. The research assessed hydromethylthionine’s mechanism of action, safety profile, and effectiveness in slowing cognitive decline in Alzheimer’s patients, contributing to the expert analysis of its role among treatment options. This evidence represents human clinical research on a pharmaceutical intervention for neurodegenerative disease.

An evaluation of hydromethylthionine as a treatment option for Alzheimer’s disease. Read Post »

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

This review article examined the potential benefits and risks of NAD+ (nicotinamide adenine dinucleotide) therapeutic approaches, including NMN supplementation, across age-related degenerative diseases by analyzing existing clinical and preclinical evidence. The authors assessed both the rationale for NAD+ augmentation in aging-related conditions and identified potential safety concerns requiring consideration in therapeutic development. This is a **review article** synthesizing existing human clinical, animal model, and in vitro research rather than original research data.

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Read Post »

The potential of GHK as an anti-aging peptide.

This review article examines the copper peptide GHK (glycine-histidine-lysine) and its proposed mechanisms for counteracting age-related biological decline, including potential effects on collagen synthesis, wound healing, and cellular signaling pathways. The authors synthesize existing evidence from multiple research domains to discuss GHK’s theoretical anti-aging potential, though the review does not present new primary data. **Evidence level: Review article** (synthesis of existing literature rather than original human clinical, animal, or in vitro research).

The potential of GHK as an anti-aging peptide. Read Post »

Are melanocortin peptides future therapeutics for cutaneous wound healing?

This review article examined the potential therapeutic role of melanocortin peptides, particularly KPV (a melanocortin receptor agonist), in promoting cutaneous wound healing through their anti-inflammatory and tissue-remodeling properties. The evidence level for this summary is a review article synthesizing existing literature rather than original clinical or experimental data. The review discusses how melanocortin peptides may modulate inflammatory responses and support various stages of wound healing, though clinical application remains investigational.

Are melanocortin peptides future therapeutics for cutaneous wound healing? Read Post »

[Anti-Aging Approach for Ocular Disorders: from Dry Eye to Retinitis Pigmentosa and Myopia].

This animal model study reviewed anti-aging approaches for treating various ocular disorders including dry eye disease, retinitis pigmentosa, and myopia, with investigation into compounds such as NMN (nicotinamide mononucleotide). The research examined how age-related cellular mechanisms contribute to these eye conditions and evaluated potential interventions targeting aging pathways. As an animal model study, these findings require further validation in human clinical trials before application to patient populations.

[Anti-Aging Approach for Ocular Disorders: from Dry Eye to Retinitis Pigmentosa and Myopia]. Read Post »

[Aging and homeostasis. Age-associated diseases and clinical application of NMN(Nicotinamide Mononucleotide).].

This review article examines the relationship between aging, homeostasis disruption, and age-associated diseases, with a focus on nicotinamide mononucleotide (NMN) as a potential clinical application (evidence level: review). The authors discuss how aging affects the body’s ability to maintain homeostasis and how this contributes to the development of chronic diseases, while exploring NMN’s proposed mechanisms in potentially addressing age-related physiological decline. The review synthesizes existing literature on NMN’s role in cellular energy metabolism and NAD+ restoration as it relates to aging and disease management.

[Aging and homeostasis. Age-associated diseases and clinical application of NMN(Nicotinamide Mononucleotide).]. Read Post »

Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction.

This animal model study investigated whether the tripeptide-copper complex GHK-Cu (II) could improve healing outcomes following anterior cruciate ligament (ACL) reconstruction in rats, finding transient improvements in the healing process. The results demonstrated temporary benefits during the healing phase, though the study did not assess long-term functional outcomes. This is an **animal model study** (rat), not human clinical evidence despite the source tag designation.

Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction. Read Post »

Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement.

Research Summary

This human clinical study investigated plasma thymosin beta-4 (Tβ4) levels in chronic ischemic heart failure patients who received intracardiac cell therapy and found that increased plasma Tβ4 was associated with symptomatic improvement in these patients. The research suggests a potential biomarker relationship between Tβ4 elevation and clinical outcomes following cell-based cardiac intervention. This is human clinical-level evidence examining the mechanistic relationship between a circulating peptide and therapeutic response in heart failure patients.

Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement. Read Post »

Scroll to Top